Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands | Total | Noncontrolling Interest - Preferred Operating Partnership | Noncontrolling Interest - Operating Partnership | Noncontrolling Interest - Other | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income | Accumulated Deficit |
Balance, beginning of period at Dec. 31, 2018 | $ 2,785,422 | $ 153,096 | $ 218,362 | $ 240 | $ 1,271 | $ 2,640,705 | $ 34,650 | $ (262,902) |
Balance, beginning of period (in shares) at Dec. 31, 2018 | | | | | 127,103,750 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Issuance of common stock upon the exercise of options | 1,757 | | | | $ 3 | 1,754 | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | 169,021 | | | |
Restricted stock grants issued (in shares) | | | | | 35,022 | | | |
Restricted stock grants cancelled (in shares) | | | | | (1,244) | | | |
Compensation expense related to stock-based awards | 2,954 | | | | | 2,954 | | |
Redemption of noncontrolling interest | | | (3,310) | | | 3,310 | | |
Redemption of Operating Partnership units (in shares) | | | | | 85,501 | | | |
Issuance of Preferred D Units in the Operating Partnership in conjunction with acquisitions | 23,447 | 23,447 | | | | | | |
Net income | 102,160 | 3,164 | 4,235 | (9) | | | | 94,770 |
Other comprehensive loss | (23,993) | (147) | (1,003) | | | | (22,843) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,412) | (3,296) | (5,116) | | | | | |
Dividends paid on common stock | (109,523) | | | | | | | (109,523) |
Balance, end of period at Mar. 31, 2019 | 2,773,812 | 176,264 | 213,168 | 231 | $ 1,274 | 2,648,723 | 11,807 | (277,655) |
Balance, end of period (in shares) at Mar. 31, 2019 | | | | | 127,392,050 | | | |
Balance, beginning of period at Dec. 31, 2018 | 2,785,422 | 153,096 | 218,362 | 240 | $ 1,271 | 2,640,705 | 34,650 | (262,902) |
Balance, beginning of period (in shares) at Dec. 31, 2018 | | | | | 127,103,750 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net income | 330,844 | | | | | | | |
Balance, end of period at Sep. 30, 2019 | 2,907,989 | 175,918 | 209,011 | 346 | $ 1,294 | 2,861,611 | (43,439) | (296,752) |
Balance, end of period (in shares) at Sep. 30, 2019 | | | | | 129,410,093 | | | |
Balance, beginning of period at Mar. 31, 2019 | 2,773,812 | 176,264 | 213,168 | 231 | $ 1,274 | 2,648,723 | 11,807 | (277,655) |
Balance, beginning of period (in shares) at Mar. 31, 2019 | | | | | 127,392,050 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Issuance of common stock upon the exercise of options | 468 | | | | | 468 | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | 17,042 | | | |
Restricted stock grants issued | 2 | | | | $ 2 | | | |
Restricted stock grants issued (in shares) | | | | | 53,789 | | | |
Restricted stock grants cancelled (in shares) | | | | | (4,786) | | | |
Issuance of common stock, net of offering costs (in shares) | | | | | 930,000 | | | |
Issuance of common stock, net of offering costs | 98,796 | | | | $ 9 | 98,787 | | |
Compensation expense related to stock-based awards | 3,998 | | | | | 3,998 | | |
Redemption of noncontrolling interest | | | (4,823) | | | 4,823 | | |
Redemption of Operating Partnership units (in shares) | | | | | 125,000 | | | |
Issuance of Preferred D Units in the Operating Partnership in conjunction with acquisitions | 4,575 | 4,575 | | | | | | |
Noncontrolling interest in consolidated joint venture | 50 | | | 50 | | | | |
Conversion of Preferred C Units in the Operating Partnership for Common Operating Partnership Units | | (4,374) | 4,374 | | | | | |
Net income | 112,689 | 3,129 | 4,754 | (22) | | | | 104,828 |
Other comprehensive loss | (41,302) | (254) | (1,765) | | | | (39,283) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,705) | (3,232) | (5,473) | | | | | |
Dividends paid on common stock | (115,572) | | | | | | | (115,572) |
Balance, end of period at Jun. 30, 2019 | 2,828,811 | 176,108 | 210,235 | 259 | $ 1,285 | 2,756,799 | (27,476) | (288,399) |
Balance, end of period (in shares) at Jun. 30, 2019 | | | | | 128,513,095 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Issuance of common stock upon the exercise of options | 605 | | | | | 605 | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | 14,850 | | | |
Restricted stock grants issued (in shares) | | | | | 5,099 | | | |
Restricted stock grants cancelled (in shares) | | | | | (1,269) | | | |
Issuance of common stock, net of offering costs (in shares) | | | | | 849,200 | | | |
Issuance of common stock, net of offering costs | 100,056 | | | | $ 9 | 100,047 | | |
Compensation expense related to stock-based awards | 3,035 | | | | | 3,035 | | |
Repayment of receivable for preferred operating units pledged as collateral on loan | 1,211 | | 1,211 | | | | | |
Redemption of noncontrolling interest | | | (1,125) | | | 1,125 | | |
Redemption of Operating Partnership units (in shares) | | | | | 29,118 | | | |
Noncontrolling interest in consolidated joint venture | 96 | | | 96 | | | | |
Net income | 115,995 | 3,089 | 4,828 | (9) | | | | 108,087 |
Other comprehensive loss | (16,762) | (101) | (698) | | | | (15,963) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,618) | (3,178) | (5,440) | | | | | |
Dividends paid on common stock | (116,440) | | | | | | | (116,440) |
Balance, end of period at Sep. 30, 2019 | 2,907,989 | 175,918 | 209,011 | 346 | $ 1,294 | 2,861,611 | (43,439) | (296,752) |
Balance, end of period (in shares) at Sep. 30, 2019 | | | | | 129,410,093 | | | |
Balance, beginning of period at Dec. 31, 2019 | $ 2,921,694 | 175,948 | 205,419 | 366 | $ 1,295 | 2,868,681 | (28,966) | (301,049) |
Balance, beginning of period (in shares) at Dec. 31, 2019 | 129,534,407 | | | | 129,534,407 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Issuance of common stock upon the exercise of options | $ 944 | | | | $ 1 | 943 | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | 77,400 | | | |
Issuance of common stock in connection with share based compensation | 2,980 | | | | $ 1 | 2,979 | | |
Issuance of common stock in connection with share based compensation (in shares) | | | | | 73,602 | | | |
Restricted stock grants cancelled (in shares) | | | | | (1,767) | | | |
Buyback of common stock, net of offering costs | (52,204) | | | | $ (7) | | | (52,197) |
Buyback of common stock, net of offering costs (in shares) | | | | | (653,597) | | | |
Redemption of noncontrolling interest | | | (330) | | | 330 | | |
Redemption of Operating Partnership units (in shares) | | | | | 8,862 | | | |
Net income | 116,162 | 3,112 | 4,877 | (6) | | | | 108,179 |
Other comprehensive loss | (89,244) | (563) | (3,807) | | | | (84,874) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,505) | (3,178) | (5,327) | | | | | |
Dividends paid on common stock | (117,197) | | | | | | | (117,197) |
Balance, end of period at Mar. 31, 2020 | 2,774,630 | 175,319 | 200,832 | 360 | $ 1,290 | 2,872,933 | (113,840) | (362,264) |
Balance, end of period (in shares) at Mar. 31, 2020 | | | | | 129,038,907 | | | |
Balance, beginning of period at Dec. 31, 2019 | $ 2,921,694 | 175,948 | 205,419 | 366 | $ 1,295 | 2,868,681 | (28,966) | (301,049) |
Balance, beginning of period (in shares) at Dec. 31, 2019 | 129,534,407 | | | | 129,534,407 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Buyback of common stock, net of offering costs (in shares) | (826,797) | | | | | | | |
Net income | $ 351,273 | | | | | | | |
Balance, end of period at Sep. 30, 2020 | $ 2,767,822 | 171,738 | 206,394 | 406 | $ 1,291 | 2,889,592 | (108,708) | (392,891) |
Balance, end of period (in shares) at Sep. 30, 2020 | 129,094,900 | | | | 129,094,900 | | | |
Balance, beginning of period at Mar. 31, 2020 | $ 2,774,630 | 175,319 | 200,832 | 360 | $ 1,290 | 2,872,933 | (113,840) | (362,264) |
Balance, beginning of period (in shares) at Mar. 31, 2020 | | | | | 129,038,907 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Issuance of common stock upon the exercise of options | 726 | | | | | 726 | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | 13,610 | | | |
Issuance of common stock in connection with share based compensation | 4,884 | | | | $ 1 | 4,883 | | |
Issuance of common stock in connection with share based compensation (in shares) | | | | | 60,032 | | | |
Restricted stock grants cancelled (in shares) | | | | | (889) | | | |
Buyback of common stock, net of offering costs | (15,615) | | | | $ (1) | | | (15,614) |
Buyback of common stock, net of offering costs (in shares) | | | | | (172,600) | | | |
Redemption of noncontrolling interest | | | (3,675) | | $ 1 | 3,674 | | |
Redemption of Operating Partnership units (in shares) | | | | | 100,000 | | | |
Redemption of Preferred D Units in the Operating Partnership for Stock (in shares) | | | | | 30,495 | | | |
Noncontrolling interest in consolidated joint venture | 68 | | | 68 | | | | |
Conversion of Preferred C Units in the Operating Partnership for Common Operating Partnership Units | | (2,724) | | | | 2,724 | | |
Net income | 111,256 | 3,138 | 5,216 | (9) | | | | 102,911 |
Other comprehensive loss | (5,727) | (40) | (271) | | | | (5,416) | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,386) | (3,151) | (5,235) | | | | | |
Dividends paid on common stock | (116,318) | | | | | | | (116,318) |
Balance, end of period at Jun. 30, 2020 | 2,745,518 | 172,542 | 196,867 | 419 | $ 1,291 | 2,884,940 | (119,256) | (391,285) |
Balance, end of period (in shares) at Jun. 30, 2020 | | | | | 129,069,555 | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Issuance of common stock upon the exercise of options | 1,200 | | | | | 1,200 | | |
Issuance of common stock upon the exercise of options (in shares) | | | | | 18,605 | | | |
Issuance of common stock in connection with share based compensation | 3,452 | | | | | 3,452 | | |
Issuance of common stock in connection with share based compensation (in shares) | | | | | 8,289 | | | |
Restricted stock grants cancelled (in shares) | | | | | (949) | | | |
Buyback of common stock, net of offering costs | (54) | | | | | | | (54) |
Buyback of common stock, net of offering costs (in shares) | | | | | (600) | | | |
Repayment of receivable for preferred operating units pledged as collateral on loan | 8,226 | | 8,226 | | | | | |
Redemption of noncontrolling interest | 1,000 | 1,000 | | | | | | |
Net income | 123,854 | 3,248 | 5,986 | (13) | | | | 114,633 |
Other comprehensive loss | 11,181 | 83 | 550 | | | | 10,548 | |
Distributions to Operating Partnership units held by noncontrolling interests | (8,370) | (3,135) | (5,235) | | | | | |
Dividends paid on common stock | (116,185) | | | | | | | (116,185) |
Balance, end of period at Sep. 30, 2020 | $ 2,767,822 | $ 171,738 | $ 206,394 | $ 406 | $ 1,291 | $ 2,889,592 | $ (108,708) | $ (392,891) |
Balance, end of period (in shares) at Sep. 30, 2020 | 129,094,900 | | | | 129,094,900 | | | |